CA-VISA-INC.
11.7.2024 22:08:28 CEST | Business Wire | Press release
With the Opening Ceremony in Paris about two weeks away, Visa (NYSE: V), the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, today announced its final roster of 147 Team Visa athletes for Paris 2024. Visa also shares ways to connect fans to the spirit of Paris 2024, both for those in attendance and those who want to participate at home.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240711202801/en/
Team Visa Olympic and Paralympic Games Paris 2024 (Photo: Business Wire)
“As the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, we’re excited to integrate Visa products and platforms that create value for both the athlete and fan experience during Paris 2024,” said Frank Cooper, CMO, Visa. “The Team Visa athletes preparing to compete in the Olympic and Paralympic Games Paris 2024 have consistently taken small steps over many years to reach this goal. We have supported these incredible athletes in their quest and want to help share their journeys with the world.”
Introducing Team Visa for Paris 2024
Founded in 2000, Team Visa has championed nearly 700 athletes over the last quarter century – each selected because of their athletic achievements, community involvement, and alignment with Visa’s core values of equality, access, and inclusion. Team Visa for Paris 2024 includes decorated Olympians and Paralympians like Simone Biles (USA, Gymnastics), Sky Brown (Great Britain, Skateboarding), Noah Lyles (USA, Athletics - Sprint) and Raissa Rocha Machado (Brazil, Para Athletics - Javelin) as well as first-timers like Shigeyuki Nakarai (Japan, Breaking) and Goodness Nwachukwu (Nigeria, Para Athletics - Discus). Team Visa also welcomes refugee athlete Dina Pouryounes (Taekwondo), forced to flee her homeland in the North of Iran to find refuge in The Netherlands.
“Visa has always been committed to empowering athletes on and off the track and it is great to see that in action,” said Noah Lyles. “I’m looking forward to getting in the blocks in Paris and putting it all out there. I have so much gratitude for my support system who has been with me every step of the way, including Team Visa.”
Team Visa by-the-numbers
- 147 athletes representing 67 countries, 40 sports, including the new Breaking competition, making this Visa’s largest, most diverse roster yet, and with 46 Paralympic athletes and hopefuls, our largest Paralympic roster to date
- 80 female and 67 male – underscoring Visa’s commitment to inclusion in sport
- Record breakers and world #1s like Iga Świątek (Poland, Tennis), PV Sindhu (India, Badminton), and Simone Biles (USA, Gymnastics)
- Newcomers and veterans alike, such as first-timers Qingyi Liu (China, Breaking) and Alexia Putellas (Spain, Football) and returners Kanoa Igarashi (Japan, Surfing) and Adam Peaty (Great Britain, Swimming)
Engaging fans in Paris and around the world
In the spirit of the theme “Pas Sans Vous,” or “Not Without You,” Visa is taking action to ensure everyone, everywhere can participate in Paris 2024:
- Visa Go, a new mobile application for Visa cardholders visiting the Olympic and Paralympic Games Paris 2024, offers access to unique experiences and exclusive content, spotlights Team Visa athletes and shares their progress during Paris 2024. The app will also offer a curated selection of discounts and offers from official partners and local shops and restaurants. Fans can purchase a virtual Visa prepaid card through Visa Go, if needed.
- Blending sports with culture, Visa has commissioned six global artists to create works of art to appear on billboards throughout Paris and other nearby host cities celebrating Paris 2024 and highlighting local commerce. In a tribute to Paris, the global capital for street art, pieces will appear on billboards in train stations, airports, the metro, and elsewhere around the cities to help support and promote local small businesses, who contribute to the city’s vitality. Participating artists include leading street artist from Seine-Saint-Denis Marko 93 (France); influential street artist and activist Swoon (USA); pioneering graffiti artist JonOne (USA); native Parisian artist Olivia De Bona (France); prolific colorblind street artist Alex Senna (Brazil); and multidisciplinary artist Vexta (Australia).
- A custom payment services solution that Visa has implemented for Paris 2024 will bring seamless contactless payment acceptance to 3,500 points of sale across 32 Olympic venues and 16 Paralympic venues.
- In recognition of Visa’s long-standing partnership with the Olympic and Paralympic Games, Paris 2024 proudly accepts only Visa for card and mobile payments, along with cash, at Olympic and Paralympic venues as well as the flagship Paris 2024 Megastore on Paris’ iconic Champs-Élysées and other official merchandise shops around France. Visa is also the Official Way to Pay for official merchandise online at the Olympic Shop.
- Fans can join the fun on Roblox at Olympic World presented by Visa, a new immersive experience that features a unique collection of sports-themed activities, quests, and fun facts.
In the Paris metro area, “Pas Sans Vous” will come to life through Visa’s commitment to giving back to local youth and small business. Visa has partnered with youth sports program Sport Dans La Ville, providing hundreds of tickets to Paris 2024 for program participants, funding new sports centers and a girls mentorship program, as well as a development program for young journalists with Le Monde, one of France’s top news platforms. Additionally, Visa invited small businesses across France to participate in the “Les Paiements Gagnants,” or “Winning Payments” national promotion, in which more than 25,000 small businesses opted in to offer Visa cardholders a chance to win Paris 2024 tickets, helping small businesses to benefit more from the commercial opportunities that the Olympic and Paralympic Games bring.
Learn more about Visa’s commitment to the Olympic and Paralympic Games here.
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711202801/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom